focus -WSS

focus

author：hotspot 2025-09-05 11:30:31 - browse：351

UnitedHealth's CEO Andrew Witty stares into the camera at a hearing with his fingers locked — politics coverage from STAT — Kent Nishimura/Getty Images

On Wednesday, UnitedHealth CEO Andrew Witty appeared before Congress to answer for what lawmakers called a “single attack [that] kicked off a cascading series of crises that are unmasking some deep vulnerabilities in the core of our health care system”: the February Change Healthcare cyberattack that is still disrupting payment processing across the country.

Senators repeatedly interrupted Witty, trying to keep him to concrete answers and promises. Lawmakers on both sides of the aisle were exasperated with UnitedHealth. At one point, Sen. Thom Tillis (R-N.C.) held up a fifth-edition copy of “Hacking for Dummies” during the hearing.

“This is some basic stuff that was missed,” he said, referring to the fact that the hackers gained access to a Change server that didn’t have multi-factor authentication, a big problem for a company whose business is digital data. “So shame on internal audit, external audit and your system folks, those tasked with redundancy, they’re not doing their job. And as a result, we have a data breach.”

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： Amylyx ALS drug fails large clinical trial

hotspot

WSS

Data don't support strong claims for Covid

Amylyx ALS drug failure raises questions and concerns

Readout LOUD podcast: Venture capital turmoil, obesity drug competition

Fight over Supreme Court dialysis ruling puts kidney patients at risk

RSV shot was 90% effective at preventing hospitalizations in kids

First medicine developed to treat MASH expected to be approved soon

hotspot

focus

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

explore

Jerome Adams on the need for new antivirals for Covid

Headspace, Meta partner to launch VR meditation app for Quest

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

The problem with charging patients to message their doctors

What does generative AI mean for health care? We asked experts

The most pressing bird flu mysteries scientists want answered

BioMarin wins approval for gene therapy to treat hemophilia A

CDC marks new Covid

At least 13 dead in Texas as scorching temps continue

ASCO Daily Recap: CAR

explore

The problem with charging patients to message their doctors

STAT wants to know your pick for a great summer read or listen

What it’s like to watch children die of measles

'Little Tech' descents on D.C., wanting a say in how AI is regulated

Readout Newsletter: Amylyx, Alto Neuro, and Eli Lilly for the Oscars

The Readout: Amylyx, Alumis, and Lundbeck drug updates

hotspot

Wikipedia

leisure time

hotspot